Nebenwirkungen · Nimvastid
Nimvastid 1.5 mg orodispersible tablets Nimvastid 3 mg orodispersible tablets Nimvastid 4.5 mg orodispersible tablets Nimvastid 6 mg orodispersible tablets · Abschnitt 4.8 · PDF-Seite 23
HOS-210228 · Präparat HOS-154463
Metabolism and nutritional disorders Common Decreased appetite Common Dehydration Psychiatric disorders Common Insomnia Common Anxiety Common Restlessness Common Hallucination, visual Common Depression Not known Aggression Nervous system disorders Very common Tremor Common Dizziness Common Somnolence Common Headache Common Parkinson’s disease (worsening) Common Bradykinesia Common Dyskinesia Common Hypokinesia Common Cogwheel rigidity Uncommon Dystonia Not known Pleurothotonus (Pisa syndrome)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-17T12:40:00Z · SHA-256 7977a2e740f93e10c6c1dbfee473c4849225e6d1d135ce94de2c91c369b45b63 · Passage ff2d2eff68d9bc86843a5fb055cf2ab63c1999853607cc1a84e0e9fb43eb6513 · Zeichen 4156–5326 im Abschnitt